Focus
Valeant Pharmaceuticals
Valeant Shares Tumble as Report Questions Company Finances
Valeant Pharmaceuticals stock plunged Wednesday after Citron Research compared the Canadian pharmaceutical company to the collapsed energy giant Enron and accused it of creating a network of phantom pharmacies to fool auditors.
